top

  Info

  • Utilizzare la checkbox di selezione a fianco di ciascun documento per attivare le funzionalità di stampa, invio email, download nei formati disponibili del (i) record.

  Info

  • Utilizzare questo link per rimuovere la selezione effettuata.

Biblioteca

MARC Lista (tabellare)
Molecular mechanisms and physiology of disease : Implications for Epigenetics and Health / / edited by Nilanjana Maulik, Tom Karagiannis
Molecular mechanisms and physiology of disease : Implications for Epigenetics and Health / / edited by Nilanjana Maulik, Tom Karagiannis
Edizione [1st ed. 2014.]
Pubbl/distr/stampa New York, NY : , : Springer New York : , : Imprint : Springer, , 2014
Descrizione fisica 1 online resource (510 p.)
Disciplina 572.6
610
611.01816
612
Soggetto topico Human physiology
Medical biochemistry
Molecular biology
Proteins 
Gene expression
Respiratory organs—Diseases
Human Physiology
Medical Biochemistry
Molecular Medicine
Protein Science
Gene Expression
Pneumology/Respiratory System
ISBN 1-4939-0706-9
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Nota di contenuto Epigenetics in Childhood Health and Disease -- Role of Epigenetics in Neural Differentiation: Implications for Health and Disease -- An Overview of Epigenetic Mechanisms in Health and Disease -- Epigenetics: Role of Histone Proteases in Cellular Functions and Diseases -- Anti-inflammatory Effects of Probiotics and their Metabolites – Possible Role for Epigenetic Effects -- Epigenetics of Autoimmune Diseases -- The Effect of Nutrition and Exercise on Epigenetics and the Development of Cardiovascular Disease -- Epigenetic Events Associated with Obesity and Diabetes -- Molecular Mechanisms in the Development and Progression of Asthma: The Role of Epigenetic Regulation and the Airway Epithelium -- The Significance of Nanoparticles in Medicine and their Potential in Asthma -- One-carbon Metabolism Nutrients and Epigenetics: A Mechanistic Link Between Aberrant One-carbon Metabolism and Cancer Risk? -- Principles of the Warburg Effect and Cancer Metabolism -- Molecular Aspects of the Warburg Effect -- Epigenetic Perturbations in the Context of the Multi-hit Hypothesis of Carcinogenesis -- Epigenetic Mechanisms of Colon Cancer Prevention -- Dietary Antioxidants and Chromatin Modifying Compounds as Potential Anticancer Therapies -- Combination Therapy for Cancer – Phototherapy and HDAC Inhibition -- Nano-base Drug Delivery Modalities for the Treatment of Cancer: The Formulation of Tumour-specific and –targeted Nanoparticles.
Record Nr. UNINA-9910298315603321
New York, NY : , : Springer New York : , : Imprint : Springer, , 2014
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Nutrition, epigenetic mechanisms, and human disease / / edited by Nilanjana Maulik and Gautam Maulik
Nutrition, epigenetic mechanisms, and human disease / / edited by Nilanjana Maulik and Gautam Maulik
Pubbl/distr/stampa Boca Raton : , : CRC Press, , 2011
Descrizione fisica 1 online resource (402 p.)
Disciplina 612.3
Altri autori (Persone) MaulikNilanjana
MaulikGautam
Soggetto topico Nutrition - Genetic aspects
Soggetto genere / forma Electronic books.
ISBN 0-429-13247-6
1-4398-0482-6
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Nota di contenuto Front Cover; Contents; Preface; Acknowledgments; The Editors; Contributors; Chapter 1: Nutritional Epigenetics and Disease Prevention : Are We There Yet?; Chapter 2: Aging by Epigenetics : Nutrition, An Epigenetic Key to Long Life; Chapter 3: Folate and DNA Methylation; Chapter 4: Dietary Components, Epigenetics, and Cancer; Chapter 5: Dietary Factors, Histone Modifications, and Cancer Prevention; Chapter 6: Nutrition, Epigenetics, and Vascular Function; Chapter 7: Role of Epigenetic Machinery and MicroRNAs in Diet-Induced Hepatocarcinogenesis
Chapter 8: Epigenetic Mechanisms in Lung Inflammation and Chronic Airway Diseases and Intervention by Dietary PolyphenolsChapter 9: Glycemic Memory and Epigenetic Changes; Chapter 10: Maternal Nutrition, Intrauterine Development, and Disease Risks in the Offspring through Epigenetic Regulation of G; Chapter 11: Nutritional Epigenetics : Impact on Metabolic Syndrome; Chapter 12: Nutrition and the Emerging Epigenetic Paradigm : Lessons from Neurobehavioral Disorders; Chapter 13: Interactions between Folate, Other B Vitamins, DNA Methylation, and Neurodevelopmental Disorders
Chapter 14: Dietary Factors and the Emerging Role of Epigenetics in Neurodegenerative DiseasesBack Cover
Record Nr. UNINA-9910459219803321
Boca Raton : , : CRC Press, , 2011
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Nutrition, epigenetic mechanisms, and human disease / / edited by Nilanjana Maulik and Gautam Maulik
Nutrition, epigenetic mechanisms, and human disease / / edited by Nilanjana Maulik and Gautam Maulik
Pubbl/distr/stampa Boca Raton : , : CRC Press, , 2011
Descrizione fisica 1 online resource (402 p.)
Disciplina 612.3
Altri autori (Persone) MaulikNilanjana
MaulikGautam
Soggetto topico Nutrition - Genetic aspects
ISBN 0-429-13247-6
1-4398-0482-6
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Nota di contenuto Front Cover; Contents; Preface; Acknowledgments; The Editors; Contributors; Chapter 1: Nutritional Epigenetics and Disease Prevention : Are We There Yet?; Chapter 2: Aging by Epigenetics : Nutrition, An Epigenetic Key to Long Life; Chapter 3: Folate and DNA Methylation; Chapter 4: Dietary Components, Epigenetics, and Cancer; Chapter 5: Dietary Factors, Histone Modifications, and Cancer Prevention; Chapter 6: Nutrition, Epigenetics, and Vascular Function; Chapter 7: Role of Epigenetic Machinery and MicroRNAs in Diet-Induced Hepatocarcinogenesis
Chapter 8: Epigenetic Mechanisms in Lung Inflammation and Chronic Airway Diseases and Intervention by Dietary PolyphenolsChapter 9: Glycemic Memory and Epigenetic Changes; Chapter 10: Maternal Nutrition, Intrauterine Development, and Disease Risks in the Offspring through Epigenetic Regulation of G; Chapter 11: Nutritional Epigenetics : Impact on Metabolic Syndrome; Chapter 12: Nutrition and the Emerging Epigenetic Paradigm : Lessons from Neurobehavioral Disorders; Chapter 13: Interactions between Folate, Other B Vitamins, DNA Methylation, and Neurodevelopmental Disorders
Chapter 14: Dietary Factors and the Emerging Role of Epigenetics in Neurodegenerative DiseasesBack Cover
Record Nr. UNINA-9910791860003321
Boca Raton : , : CRC Press, , 2011
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Nutrition, epigenetic mechanisms, and human disease / / edited by Nilanjana Maulik and Gautam Maulik
Nutrition, epigenetic mechanisms, and human disease / / edited by Nilanjana Maulik and Gautam Maulik
Pubbl/distr/stampa Boca Raton : , : CRC Press, , 2011
Descrizione fisica 1 online resource (402 p.)
Disciplina 612.3
Altri autori (Persone) MaulikNilanjana
MaulikGautam
Soggetto topico Nutrition - Genetic aspects
ISBN 0-429-13247-6
1-4398-0482-6
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Nota di contenuto Front Cover; Contents; Preface; Acknowledgments; The Editors; Contributors; Chapter 1: Nutritional Epigenetics and Disease Prevention : Are We There Yet?; Chapter 2: Aging by Epigenetics : Nutrition, An Epigenetic Key to Long Life; Chapter 3: Folate and DNA Methylation; Chapter 4: Dietary Components, Epigenetics, and Cancer; Chapter 5: Dietary Factors, Histone Modifications, and Cancer Prevention; Chapter 6: Nutrition, Epigenetics, and Vascular Function; Chapter 7: Role of Epigenetic Machinery and MicroRNAs in Diet-Induced Hepatocarcinogenesis
Chapter 8: Epigenetic Mechanisms in Lung Inflammation and Chronic Airway Diseases and Intervention by Dietary PolyphenolsChapter 9: Glycemic Memory and Epigenetic Changes; Chapter 10: Maternal Nutrition, Intrauterine Development, and Disease Risks in the Offspring through Epigenetic Regulation of G; Chapter 11: Nutritional Epigenetics : Impact on Metabolic Syndrome; Chapter 12: Nutrition and the Emerging Epigenetic Paradigm : Lessons from Neurobehavioral Disorders; Chapter 13: Interactions between Folate, Other B Vitamins, DNA Methylation, and Neurodevelopmental Disorders
Chapter 14: Dietary Factors and the Emerging Role of Epigenetics in Neurodegenerative DiseasesBack Cover
Record Nr. UNINA-9910799985803321
Boca Raton : , : CRC Press, , 2011
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Nutrition, epigenetic mechanisms, and human disease / / edited by Nilanjana Maulik and Gautam Maulik
Nutrition, epigenetic mechanisms, and human disease / / edited by Nilanjana Maulik and Gautam Maulik
Edizione [1st ed.]
Pubbl/distr/stampa Boca Raton : , : CRC Press, , 2011
Descrizione fisica 1 online resource (402 p.)
Disciplina 612.3
Altri autori (Persone) MaulikNilanjana
MaulikGautam
Soggetto topico Nutrition - Genetic aspects
ISBN 1-04-006778-6
0-429-13247-6
1-4398-0482-6
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Nota di contenuto Front Cover; Contents; Preface; Acknowledgments; The Editors; Contributors; Chapter 1: Nutritional Epigenetics and Disease Prevention : Are We There Yet?; Chapter 2: Aging by Epigenetics : Nutrition, An Epigenetic Key to Long Life; Chapter 3: Folate and DNA Methylation; Chapter 4: Dietary Components, Epigenetics, and Cancer; Chapter 5: Dietary Factors, Histone Modifications, and Cancer Prevention; Chapter 6: Nutrition, Epigenetics, and Vascular Function; Chapter 7: Role of Epigenetic Machinery and MicroRNAs in Diet-Induced Hepatocarcinogenesis
Chapter 8: Epigenetic Mechanisms in Lung Inflammation and Chronic Airway Diseases and Intervention by Dietary PolyphenolsChapter 9: Glycemic Memory and Epigenetic Changes; Chapter 10: Maternal Nutrition, Intrauterine Development, and Disease Risks in the Offspring through Epigenetic Regulation of G; Chapter 11: Nutritional Epigenetics : Impact on Metabolic Syndrome; Chapter 12: Nutrition and the Emerging Epigenetic Paradigm : Lessons from Neurobehavioral Disorders; Chapter 13: Interactions between Folate, Other B Vitamins, DNA Methylation, and Neurodevelopmental Disorders
Chapter 14: Dietary Factors and the Emerging Role of Epigenetics in Neurodegenerative DiseasesBack Cover
Record Nr. UNINA-9910818037703321
Boca Raton : , : CRC Press, , 2011
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Personalized nutrition as medical therapy for high risk diseases / / edited by Nilanjana Maulik
Personalized nutrition as medical therapy for high risk diseases / / edited by Nilanjana Maulik
Pubbl/distr/stampa Boca Raton, Florida ; ; London, England ; ; New York : , : CRC Press, , [2020]
Descrizione fisica 1 online resource (365 pages)
Disciplina 615.854
Soggetto topico Diet therapy
Personalized medicine
ISBN 1-351-62183-1
1-315-11237-X
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Nota di contenuto Cover -- Half Title -- Title Page -- Copyright Page -- Dedication -- Table of Contents -- Preface -- Acknowledgments -- Editor -- Contributors -- Chapter 1 Introduction -- 1.1 Introduction -- 1.2 What Does Personalization Mean -- 1.3 Where to Go from Here -- 1.4 Medicalization of Food -- 1.5 The Genome-Based Health Concept -- 1.6 Way Forward -- References -- Chapter 2 Personalized Nutrition: The New Era of Nutrition -- 2.1 Introduction -- 2.1.1 Defining Personalized Nutrition -- 2.1.2 Origins of Personalized Nutrition as a Formal Scientific Ideology -- 2.2 Theoretical Basis for Personalized Nutrition -- 2.3 Current Perspectives on Personalized Nutrition -- 2.3.1 Nutrient-Gene Interactions -- 2.3.1.1 Biomarkers -- 2.3.2 Altering Human Behavior -- 2.3.3 Age and Stages of Life -- 2.3.4 Gender -- 2.3.5 Environment: The Exposome -- 2.3.5.1 The Microbiome -- 2.3.6 Personalized Nutritional Strategies for Athletic Performance -- 2.4 Closing Remarks -- Abbreviations -- References -- Chapter 3 Personalized Nutrition in Cardiovascular Disease: From Concept to Realization -- 3.1 Epidemiology -- 3.2 Personalized Nutrition (PN) in CVD -- 3.3 PN1: A Healthy Reference Diet for CVD -- 3.4 Diet and CVD: Lessons from and Limitations of Observational Studies -- 3.5 Saturated Fat (SFA) Intake and CVD -- 3.6 Fat Quality and CVD -- 3.7 Protein Intake and CVD Risk -- 3.8 Carbohydrate Intake and CVD Risk -- 3.8.1 Glycemic Index/Load (GI/GL) -- 3.8.2 Fiber -- 3.8.3 Glucose/Fructose -- 3.9 Dietary Cholesterol and Plant Sterols and Stanols and CVD Risk -- 3.9.1 Dietary Cholesterol -- 3.9.2 Plant Sterols and Stanols -- 3.9.3 Salt Intake and CVD Risk -- 3.10 PN1: Healthy Diet Recommendations for Patients with, or at Risk of, CVD -- 3.11 PN2: Tailoring Dietary Advice to Manage CVD Based on a Person's Phenotype.
3.12 PN3: Tailoring Nutritional Advice to Genetic Composition: From Concept to Realization -- 3.13 Genetics and CVD: Testing the Nature versus Nurture Hypothesis -- 3.14 GWAS and CVD -- 3.15 PN3: Proof of Concept from LIPGENE -- 3.16 PN3: The Challenge of Keeping Up with GWAS -- 3.17 Perspective on the Future of PN for CVD: Is Society Ready to Embrace Change? -- Abbreviations -- References -- Chapter 4 Nutraceuticals for Hypertension Control -- 4.1 Hypertension -- 4.2 Epidemiology -- 4.3 Hypertension Can Be Classified into Two Forms: Primary and Secondary -- 4.3.1 Primary Hypertension -- 4.3.1.1 Genetic Factors -- 4.3.1.2 Environmental Factors -- 4.3.1.3 Childhood Risk for Hypertension -- 4.3.2 Secondary Hypertension -- 4.3.3 Complications of Hypertension -- 4.3.4 Treatment of Hypertension -- 4.4 Minerals and Hypertension -- 4.4.1 Sodium -- 4.4.2 Potassium -- 4.4.3 Magnesium -- 4.4.4 Calcium -- 4.4.5 Zinc -- 4.4.6 Copper -- 4.4.7 Chromium -- 4.4.8 Selenium -- 4.4.9 Manganese -- 4.5 Macronutrients Affecting Hypertension -- 4.5.1 Protein -- 4.5.2 Fat and Fatty Acids -- 4.5.3 Carbohydrates -- 4.5.4 Fibers -- 4.6 Micronutrients and Hypertension -- 4.6.1 Vitamins -- 4.6.2 Coenzyme Q10 (Ubiquinone -- 4.7 Antihypertensive Herbs and Their Mechanism of Action -- 4.7.1 Antioxidant Defense -- 4.7.1.1 Flavonoids -- 4.7.1.2 Vitis vinifera (Grapevine)-Resveratrol -- 4.7.1.3 Lycopersicon esculentum (Tomato)-Lycopene -- 4.7.1.4 Camellia sinensis (Green Tea -- 4.7.2 Diuretics -- 4.7.2.1 Taraxacum officinale (Dandelion -- 4.7.2.2 Petroselinum crispus (Parsley -- 4.7.2.3 Urtica dioica (Stinging Nettle -- 4.7.3 ACE-Inhibitors -- 4.7.3.1 Allium ursinum (Ramsons -- 4.7.3.2 Zingiber officinale (Ginger -- 4.7.3.3 Angelica sinensis (Danggui -- 4.7.4 Vasorelaxant Activity: Direct Vasodilators -- 4.7.4.1 Allium cepa (Onion -- 4.7.4.2 Allium sativum (Garlic.
4.7.4.3 Cinnamomum zeylanicum (Cinnamon -- 4.7.5 Calcium Channel Blocker (CCB -- 4.7.5.1 Piper nigrum (Black Pepper -- 4.8 Interactions of Antihypertensive Herbs -- 4.9 Conclusions -- Acknowledgment -- Abbreviations -- References -- Chapter 5 Roles of Daily Diet and Beta-Adrenergic System in the Treatment of Obesity and Diabetes -- 5.1 Introduction -- 5.2 Role of Nutrition in the Development of Diabetes and Obesity -- 5.2.1 Nutrition in Diabetes -- 5.2.1.1 Micronutrients in Diabetes -- 5.2.1.2 Anthocyanins -- 5.2.1.3 Cocoa Flavanols -- 5.2.1.4 Resveratrol -- 5.2.1.5 Cinnamon -- 5.2.1.6 Milk and Dairy Products -- 5.2.1.7 Probiotics -- 5.2.2 Nutrition in Obesity -- 5.2.2.1 Probiotics -- 5.2.2.2 Quercetin -- 5.2.2.3 Resveratrol -- 5.2.2.4 Curcumin -- 5.2.2.5 Sulforaphane -- 5.3 Role of Nutrition in the Function of the Cardiovascular System -- 5.4 Cardiac Function in Diabetes and Obesity -- 5.4.1 Cardiac Dysfunction in Diabetes -- 5.4.2 Cardiac Function in Obesity -- 5.5 Diet and Beta-Adrenergic System Relation in Heart Function -- 5.6 Effect of ß-ARs System on Heart Function in Diabetes and Obesity -- 5.7 ß3-ARs in Diabetes and Obesity -- 5.8 Regulation of ß3-ARs in Heart from Diabetic and Obese Mammalians -- 5.9 Conclusions -- Acknowledgment -- Abbreviations -- References -- Chapter 6 High Carbohydrate Diet-Induced Metabolic Syndrome in the Overweight Body: Association between Organ Dysfunction and Insulin Resistance -- 6.1 Introduction -- 6.2 Carbohydrate-Rich Nutrition and MetS -- 6.3 MetS and Cardiovascular Dysfunction -- 6.4 Structural Alterations and Molecular Mechanisms of Cardiovascular Dysfunction in MetS -- 6.5 Electrical Alterations in the Hearts of MetS Individuals -- 6.6 Cellular Abnormalities in Ca2+ Homeostasis and Insulin Action in Mammalian MetS -- 6.7 Conclusions and Prevention Approaches -- Acknowledgments -- Abbreviations.
References -- Chapter 7 Caloric Restriction in Obesity and Diabetic Heart Disease -- 7.1 Introduction -- 7.1.1 Cardiovascular Consequences of Diabetes -- 7.2 Metabolic and Molecular Consequences of Diabetes -- 7.2.1 Oxidative Stress -- 7.2.2 Enhanced Inflammatory Response -- 7.2.3 Enhanced Cardiac Fibrosis -- 7.3 Modern Medical Therapies: Implications for the 'Diabetic' Heart -- 7.3.1 Pharmacological Approach, Bariatric Surgery, Intragastric Balloon -- 7.4 Lifestyle Modification -- 7.4.1 Caloric Restriction (CR) -- 7.4.1.1 CR Intracellular Mode of Action -- 7.4.2 Sirtuins -- 7.4.3 PGC-1a -- 7.5 Summary and Future Perspectives -- Abbreviations -- References -- Chapter 8 Personalized Nutrition in Children with Crohn Disease -- 8.1 Introduction -- 8.2 Crohn Disease: An Inflammatory Bowel Disease -- 8.2.1 Crohn Disease and Ulcerative Colitis -- 8.2.2 Pathogenesis of IBD -- 8.2.3 Presentation and Epidemiology of IBD -- 8.2.4 Diagnosis of CD -- 8.3 Relevance of Nutrition and Dietary Factors in the Development of IBD -- 8.4 Nutritional Impacts of CD in Children -- 8.5 Nutritional Therapy for Children with Active CD -- 8.5.1 Induction of Remission with Exclusive Enteral Nutrition -- 8.6 General Aspects of Nutritional Management in Children with IBD -- 8.6.1 Overall Nutritional Care -- 8.6.2 Dietary Management of Functional Symptoms in Children with CD -- 8.7 Application of Current Understanding to the Development of Personalized Nutrition for Children with CD -- 8.7.1 Concepts to Guide Personalized Nutrition -- 8.7.2 Personalization of Nutritional Therapy to Induce Remission -- 8.7.3 Patient and Disease-Specific Factors to Guide Dietary Choices -- 8.7.4 Nutrigenomics, Nutrigenetics and Nutriepigenetics -- 8.8 Conclusions -- Abbreviations -- References -- Chapter 9 Personalized Nutrition in Chronic Kidney Disease: A New Challenge.
9.1 Chronic Kidney Disease: An Epidemic That Reflects Socio-Economic Differences -- 9.1.1 Kidney Diseases Are Not Rare: A Problem of Measure -- 9.1.2 The Main Markers of Kidney Function Are Also Basic Nutritional Markers -- 9.1.3 CKD Assessment: What Is Missed -- 9.1.4 The Epidemiology of Kidney Diseases Follows Wealth Distribution -- 9.2 Nutritional Approach to CKD: Ten Reasons Why One Size Does Not Fit All -- 9.2.1 Kidney Diseases Are Different -- 9.2.2 CKD Phases Are Different -- 9.2.3 Comorbidity Is Different -- 9.2.4 Cultures Are Different -- 9.2.5 Dietary Habits Are Different -- 9.2.6 Availability of Nutritional Support Is Different -- 9.2.7 Nephrologists (and Dietitians) Are Different -- 9.2.8 Life Phases Are Different -- 9.2.9 Patients Are Different -- 9.2.10 Most of the Previous Points May Change -- 9.3 Nutritional Issues in Different Phases of CKD -- 9.3.1 Early CKD Phases: Nephron Sparing -- 9.3.2 Late CKD Phases: Retarding Dialysis Start -- 9.3.3 Dialysis: Preserving Nutritional Status -- 9.3.4 Kidney Transplantation: Preserving Nutritional Status and Slowing CKD Progression -- 9.4 Some Suggestions on Specific Nutritional Issues in Different Diseases -- 9.4.1 Nephrotic Syndrome and the Case of Focal Segmental Glomerulosclerosis -- 9.4.2 Obesity-Related Kidney Disease and Diabetic Nephropathy -- 9.4.3 Autosomal Dominant Polycystic Kidney Disease (ADPKD) -- 9.4.4 Interstitial Disorders and Kidney Stones -- 9.4.5 Kidney Donation -- 9.5 Nutritional Issues in Particular CKD Populations -- 9.5.1 Pregnant Women with CKD -- 9.5.2 Children with CKD -- 9.6 What This Review Did Not Discuss: Suggestions for Further Research -- 9.7 Concluding Remarks -- Abbreviations -- References -- Chapter 10 Personalized Nutrition in Hypercholesterolemia -- 10.1 Personalized Nutrition in Hypercholesterolemia -- 10.2 Cardiovascular Diseases (CVD).
10.3 Coronary Heart Disease (CHD).
Record Nr. UNINA-9910794143903321
Boca Raton, Florida ; ; London, England ; ; New York : , : CRC Press, , [2020]
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Personalized nutrition as medical therapy for high risk diseases / / edited by Nilanjana Maulik
Personalized nutrition as medical therapy for high risk diseases / / edited by Nilanjana Maulik
Pubbl/distr/stampa Boca Raton, Florida ; ; London, England ; ; New York : , : CRC Press, , [2020]
Descrizione fisica 1 online resource (365 pages)
Disciplina 615.854
Soggetto topico Diet therapy
Personalized medicine
ISBN 1-351-62183-1
1-315-11237-X
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Nota di contenuto Cover -- Half Title -- Title Page -- Copyright Page -- Dedication -- Table of Contents -- Preface -- Acknowledgments -- Editor -- Contributors -- Chapter 1 Introduction -- 1.1 Introduction -- 1.2 What Does Personalization Mean -- 1.3 Where to Go from Here -- 1.4 Medicalization of Food -- 1.5 The Genome-Based Health Concept -- 1.6 Way Forward -- References -- Chapter 2 Personalized Nutrition: The New Era of Nutrition -- 2.1 Introduction -- 2.1.1 Defining Personalized Nutrition -- 2.1.2 Origins of Personalized Nutrition as a Formal Scientific Ideology -- 2.2 Theoretical Basis for Personalized Nutrition -- 2.3 Current Perspectives on Personalized Nutrition -- 2.3.1 Nutrient-Gene Interactions -- 2.3.1.1 Biomarkers -- 2.3.2 Altering Human Behavior -- 2.3.3 Age and Stages of Life -- 2.3.4 Gender -- 2.3.5 Environment: The Exposome -- 2.3.5.1 The Microbiome -- 2.3.6 Personalized Nutritional Strategies for Athletic Performance -- 2.4 Closing Remarks -- Abbreviations -- References -- Chapter 3 Personalized Nutrition in Cardiovascular Disease: From Concept to Realization -- 3.1 Epidemiology -- 3.2 Personalized Nutrition (PN) in CVD -- 3.3 PN1: A Healthy Reference Diet for CVD -- 3.4 Diet and CVD: Lessons from and Limitations of Observational Studies -- 3.5 Saturated Fat (SFA) Intake and CVD -- 3.6 Fat Quality and CVD -- 3.7 Protein Intake and CVD Risk -- 3.8 Carbohydrate Intake and CVD Risk -- 3.8.1 Glycemic Index/Load (GI/GL) -- 3.8.2 Fiber -- 3.8.3 Glucose/Fructose -- 3.9 Dietary Cholesterol and Plant Sterols and Stanols and CVD Risk -- 3.9.1 Dietary Cholesterol -- 3.9.2 Plant Sterols and Stanols -- 3.9.3 Salt Intake and CVD Risk -- 3.10 PN1: Healthy Diet Recommendations for Patients with, or at Risk of, CVD -- 3.11 PN2: Tailoring Dietary Advice to Manage CVD Based on a Person's Phenotype.
3.12 PN3: Tailoring Nutritional Advice to Genetic Composition: From Concept to Realization -- 3.13 Genetics and CVD: Testing the Nature versus Nurture Hypothesis -- 3.14 GWAS and CVD -- 3.15 PN3: Proof of Concept from LIPGENE -- 3.16 PN3: The Challenge of Keeping Up with GWAS -- 3.17 Perspective on the Future of PN for CVD: Is Society Ready to Embrace Change? -- Abbreviations -- References -- Chapter 4 Nutraceuticals for Hypertension Control -- 4.1 Hypertension -- 4.2 Epidemiology -- 4.3 Hypertension Can Be Classified into Two Forms: Primary and Secondary -- 4.3.1 Primary Hypertension -- 4.3.1.1 Genetic Factors -- 4.3.1.2 Environmental Factors -- 4.3.1.3 Childhood Risk for Hypertension -- 4.3.2 Secondary Hypertension -- 4.3.3 Complications of Hypertension -- 4.3.4 Treatment of Hypertension -- 4.4 Minerals and Hypertension -- 4.4.1 Sodium -- 4.4.2 Potassium -- 4.4.3 Magnesium -- 4.4.4 Calcium -- 4.4.5 Zinc -- 4.4.6 Copper -- 4.4.7 Chromium -- 4.4.8 Selenium -- 4.4.9 Manganese -- 4.5 Macronutrients Affecting Hypertension -- 4.5.1 Protein -- 4.5.2 Fat and Fatty Acids -- 4.5.3 Carbohydrates -- 4.5.4 Fibers -- 4.6 Micronutrients and Hypertension -- 4.6.1 Vitamins -- 4.6.2 Coenzyme Q10 (Ubiquinone -- 4.7 Antihypertensive Herbs and Their Mechanism of Action -- 4.7.1 Antioxidant Defense -- 4.7.1.1 Flavonoids -- 4.7.1.2 Vitis vinifera (Grapevine)-Resveratrol -- 4.7.1.3 Lycopersicon esculentum (Tomato)-Lycopene -- 4.7.1.4 Camellia sinensis (Green Tea -- 4.7.2 Diuretics -- 4.7.2.1 Taraxacum officinale (Dandelion -- 4.7.2.2 Petroselinum crispus (Parsley -- 4.7.2.3 Urtica dioica (Stinging Nettle -- 4.7.3 ACE-Inhibitors -- 4.7.3.1 Allium ursinum (Ramsons -- 4.7.3.2 Zingiber officinale (Ginger -- 4.7.3.3 Angelica sinensis (Danggui -- 4.7.4 Vasorelaxant Activity: Direct Vasodilators -- 4.7.4.1 Allium cepa (Onion -- 4.7.4.2 Allium sativum (Garlic.
4.7.4.3 Cinnamomum zeylanicum (Cinnamon -- 4.7.5 Calcium Channel Blocker (CCB -- 4.7.5.1 Piper nigrum (Black Pepper -- 4.8 Interactions of Antihypertensive Herbs -- 4.9 Conclusions -- Acknowledgment -- Abbreviations -- References -- Chapter 5 Roles of Daily Diet and Beta-Adrenergic System in the Treatment of Obesity and Diabetes -- 5.1 Introduction -- 5.2 Role of Nutrition in the Development of Diabetes and Obesity -- 5.2.1 Nutrition in Diabetes -- 5.2.1.1 Micronutrients in Diabetes -- 5.2.1.2 Anthocyanins -- 5.2.1.3 Cocoa Flavanols -- 5.2.1.4 Resveratrol -- 5.2.1.5 Cinnamon -- 5.2.1.6 Milk and Dairy Products -- 5.2.1.7 Probiotics -- 5.2.2 Nutrition in Obesity -- 5.2.2.1 Probiotics -- 5.2.2.2 Quercetin -- 5.2.2.3 Resveratrol -- 5.2.2.4 Curcumin -- 5.2.2.5 Sulforaphane -- 5.3 Role of Nutrition in the Function of the Cardiovascular System -- 5.4 Cardiac Function in Diabetes and Obesity -- 5.4.1 Cardiac Dysfunction in Diabetes -- 5.4.2 Cardiac Function in Obesity -- 5.5 Diet and Beta-Adrenergic System Relation in Heart Function -- 5.6 Effect of ß-ARs System on Heart Function in Diabetes and Obesity -- 5.7 ß3-ARs in Diabetes and Obesity -- 5.8 Regulation of ß3-ARs in Heart from Diabetic and Obese Mammalians -- 5.9 Conclusions -- Acknowledgment -- Abbreviations -- References -- Chapter 6 High Carbohydrate Diet-Induced Metabolic Syndrome in the Overweight Body: Association between Organ Dysfunction and Insulin Resistance -- 6.1 Introduction -- 6.2 Carbohydrate-Rich Nutrition and MetS -- 6.3 MetS and Cardiovascular Dysfunction -- 6.4 Structural Alterations and Molecular Mechanisms of Cardiovascular Dysfunction in MetS -- 6.5 Electrical Alterations in the Hearts of MetS Individuals -- 6.6 Cellular Abnormalities in Ca2+ Homeostasis and Insulin Action in Mammalian MetS -- 6.7 Conclusions and Prevention Approaches -- Acknowledgments -- Abbreviations.
References -- Chapter 7 Caloric Restriction in Obesity and Diabetic Heart Disease -- 7.1 Introduction -- 7.1.1 Cardiovascular Consequences of Diabetes -- 7.2 Metabolic and Molecular Consequences of Diabetes -- 7.2.1 Oxidative Stress -- 7.2.2 Enhanced Inflammatory Response -- 7.2.3 Enhanced Cardiac Fibrosis -- 7.3 Modern Medical Therapies: Implications for the 'Diabetic' Heart -- 7.3.1 Pharmacological Approach, Bariatric Surgery, Intragastric Balloon -- 7.4 Lifestyle Modification -- 7.4.1 Caloric Restriction (CR) -- 7.4.1.1 CR Intracellular Mode of Action -- 7.4.2 Sirtuins -- 7.4.3 PGC-1a -- 7.5 Summary and Future Perspectives -- Abbreviations -- References -- Chapter 8 Personalized Nutrition in Children with Crohn Disease -- 8.1 Introduction -- 8.2 Crohn Disease: An Inflammatory Bowel Disease -- 8.2.1 Crohn Disease and Ulcerative Colitis -- 8.2.2 Pathogenesis of IBD -- 8.2.3 Presentation and Epidemiology of IBD -- 8.2.4 Diagnosis of CD -- 8.3 Relevance of Nutrition and Dietary Factors in the Development of IBD -- 8.4 Nutritional Impacts of CD in Children -- 8.5 Nutritional Therapy for Children with Active CD -- 8.5.1 Induction of Remission with Exclusive Enteral Nutrition -- 8.6 General Aspects of Nutritional Management in Children with IBD -- 8.6.1 Overall Nutritional Care -- 8.6.2 Dietary Management of Functional Symptoms in Children with CD -- 8.7 Application of Current Understanding to the Development of Personalized Nutrition for Children with CD -- 8.7.1 Concepts to Guide Personalized Nutrition -- 8.7.2 Personalization of Nutritional Therapy to Induce Remission -- 8.7.3 Patient and Disease-Specific Factors to Guide Dietary Choices -- 8.7.4 Nutrigenomics, Nutrigenetics and Nutriepigenetics -- 8.8 Conclusions -- Abbreviations -- References -- Chapter 9 Personalized Nutrition in Chronic Kidney Disease: A New Challenge.
9.1 Chronic Kidney Disease: An Epidemic That Reflects Socio-Economic Differences -- 9.1.1 Kidney Diseases Are Not Rare: A Problem of Measure -- 9.1.2 The Main Markers of Kidney Function Are Also Basic Nutritional Markers -- 9.1.3 CKD Assessment: What Is Missed -- 9.1.4 The Epidemiology of Kidney Diseases Follows Wealth Distribution -- 9.2 Nutritional Approach to CKD: Ten Reasons Why One Size Does Not Fit All -- 9.2.1 Kidney Diseases Are Different -- 9.2.2 CKD Phases Are Different -- 9.2.3 Comorbidity Is Different -- 9.2.4 Cultures Are Different -- 9.2.5 Dietary Habits Are Different -- 9.2.6 Availability of Nutritional Support Is Different -- 9.2.7 Nephrologists (and Dietitians) Are Different -- 9.2.8 Life Phases Are Different -- 9.2.9 Patients Are Different -- 9.2.10 Most of the Previous Points May Change -- 9.3 Nutritional Issues in Different Phases of CKD -- 9.3.1 Early CKD Phases: Nephron Sparing -- 9.3.2 Late CKD Phases: Retarding Dialysis Start -- 9.3.3 Dialysis: Preserving Nutritional Status -- 9.3.4 Kidney Transplantation: Preserving Nutritional Status and Slowing CKD Progression -- 9.4 Some Suggestions on Specific Nutritional Issues in Different Diseases -- 9.4.1 Nephrotic Syndrome and the Case of Focal Segmental Glomerulosclerosis -- 9.4.2 Obesity-Related Kidney Disease and Diabetic Nephropathy -- 9.4.3 Autosomal Dominant Polycystic Kidney Disease (ADPKD) -- 9.4.4 Interstitial Disorders and Kidney Stones -- 9.4.5 Kidney Donation -- 9.5 Nutritional Issues in Particular CKD Populations -- 9.5.1 Pregnant Women with CKD -- 9.5.2 Children with CKD -- 9.6 What This Review Did Not Discuss: Suggestions for Further Research -- 9.7 Concluding Remarks -- Abbreviations -- References -- Chapter 10 Personalized Nutrition in Hypercholesterolemia -- 10.1 Personalized Nutrition in Hypercholesterolemia -- 10.2 Cardiovascular Diseases (CVD).
10.3 Coronary Heart Disease (CHD).
Record Nr. UNINA-9910799933503321
Boca Raton, Florida ; ; London, England ; ; New York : , : CRC Press, , [2020]
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Personalized nutrition as medical therapy for high risk diseases / / edited by Nilanjana Maulik
Personalized nutrition as medical therapy for high risk diseases / / edited by Nilanjana Maulik
Pubbl/distr/stampa Boca Raton, Florida ; ; London, England ; ; New York : , : CRC Press, , [2020]
Descrizione fisica 1 online resource (365 pages)
Disciplina 615.854
Soggetto topico Diet therapy
Personalized medicine
ISBN 1-351-62183-1
1-315-11237-X
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Nota di contenuto Cover -- Half Title -- Title Page -- Copyright Page -- Dedication -- Table of Contents -- Preface -- Acknowledgments -- Editor -- Contributors -- Chapter 1 Introduction -- 1.1 Introduction -- 1.2 What Does Personalization Mean -- 1.3 Where to Go from Here -- 1.4 Medicalization of Food -- 1.5 The Genome-Based Health Concept -- 1.6 Way Forward -- References -- Chapter 2 Personalized Nutrition: The New Era of Nutrition -- 2.1 Introduction -- 2.1.1 Defining Personalized Nutrition -- 2.1.2 Origins of Personalized Nutrition as a Formal Scientific Ideology -- 2.2 Theoretical Basis for Personalized Nutrition -- 2.3 Current Perspectives on Personalized Nutrition -- 2.3.1 Nutrient-Gene Interactions -- 2.3.1.1 Biomarkers -- 2.3.2 Altering Human Behavior -- 2.3.3 Age and Stages of Life -- 2.3.4 Gender -- 2.3.5 Environment: The Exposome -- 2.3.5.1 The Microbiome -- 2.3.6 Personalized Nutritional Strategies for Athletic Performance -- 2.4 Closing Remarks -- Abbreviations -- References -- Chapter 3 Personalized Nutrition in Cardiovascular Disease: From Concept to Realization -- 3.1 Epidemiology -- 3.2 Personalized Nutrition (PN) in CVD -- 3.3 PN1: A Healthy Reference Diet for CVD -- 3.4 Diet and CVD: Lessons from and Limitations of Observational Studies -- 3.5 Saturated Fat (SFA) Intake and CVD -- 3.6 Fat Quality and CVD -- 3.7 Protein Intake and CVD Risk -- 3.8 Carbohydrate Intake and CVD Risk -- 3.8.1 Glycemic Index/Load (GI/GL) -- 3.8.2 Fiber -- 3.8.3 Glucose/Fructose -- 3.9 Dietary Cholesterol and Plant Sterols and Stanols and CVD Risk -- 3.9.1 Dietary Cholesterol -- 3.9.2 Plant Sterols and Stanols -- 3.9.3 Salt Intake and CVD Risk -- 3.10 PN1: Healthy Diet Recommendations for Patients with, or at Risk of, CVD -- 3.11 PN2: Tailoring Dietary Advice to Manage CVD Based on a Person's Phenotype.
3.12 PN3: Tailoring Nutritional Advice to Genetic Composition: From Concept to Realization -- 3.13 Genetics and CVD: Testing the Nature versus Nurture Hypothesis -- 3.14 GWAS and CVD -- 3.15 PN3: Proof of Concept from LIPGENE -- 3.16 PN3: The Challenge of Keeping Up with GWAS -- 3.17 Perspective on the Future of PN for CVD: Is Society Ready to Embrace Change? -- Abbreviations -- References -- Chapter 4 Nutraceuticals for Hypertension Control -- 4.1 Hypertension -- 4.2 Epidemiology -- 4.3 Hypertension Can Be Classified into Two Forms: Primary and Secondary -- 4.3.1 Primary Hypertension -- 4.3.1.1 Genetic Factors -- 4.3.1.2 Environmental Factors -- 4.3.1.3 Childhood Risk for Hypertension -- 4.3.2 Secondary Hypertension -- 4.3.3 Complications of Hypertension -- 4.3.4 Treatment of Hypertension -- 4.4 Minerals and Hypertension -- 4.4.1 Sodium -- 4.4.2 Potassium -- 4.4.3 Magnesium -- 4.4.4 Calcium -- 4.4.5 Zinc -- 4.4.6 Copper -- 4.4.7 Chromium -- 4.4.8 Selenium -- 4.4.9 Manganese -- 4.5 Macronutrients Affecting Hypertension -- 4.5.1 Protein -- 4.5.2 Fat and Fatty Acids -- 4.5.3 Carbohydrates -- 4.5.4 Fibers -- 4.6 Micronutrients and Hypertension -- 4.6.1 Vitamins -- 4.6.2 Coenzyme Q10 (Ubiquinone -- 4.7 Antihypertensive Herbs and Their Mechanism of Action -- 4.7.1 Antioxidant Defense -- 4.7.1.1 Flavonoids -- 4.7.1.2 Vitis vinifera (Grapevine)-Resveratrol -- 4.7.1.3 Lycopersicon esculentum (Tomato)-Lycopene -- 4.7.1.4 Camellia sinensis (Green Tea -- 4.7.2 Diuretics -- 4.7.2.1 Taraxacum officinale (Dandelion -- 4.7.2.2 Petroselinum crispus (Parsley -- 4.7.2.3 Urtica dioica (Stinging Nettle -- 4.7.3 ACE-Inhibitors -- 4.7.3.1 Allium ursinum (Ramsons -- 4.7.3.2 Zingiber officinale (Ginger -- 4.7.3.3 Angelica sinensis (Danggui -- 4.7.4 Vasorelaxant Activity: Direct Vasodilators -- 4.7.4.1 Allium cepa (Onion -- 4.7.4.2 Allium sativum (Garlic.
4.7.4.3 Cinnamomum zeylanicum (Cinnamon -- 4.7.5 Calcium Channel Blocker (CCB -- 4.7.5.1 Piper nigrum (Black Pepper -- 4.8 Interactions of Antihypertensive Herbs -- 4.9 Conclusions -- Acknowledgment -- Abbreviations -- References -- Chapter 5 Roles of Daily Diet and Beta-Adrenergic System in the Treatment of Obesity and Diabetes -- 5.1 Introduction -- 5.2 Role of Nutrition in the Development of Diabetes and Obesity -- 5.2.1 Nutrition in Diabetes -- 5.2.1.1 Micronutrients in Diabetes -- 5.2.1.2 Anthocyanins -- 5.2.1.3 Cocoa Flavanols -- 5.2.1.4 Resveratrol -- 5.2.1.5 Cinnamon -- 5.2.1.6 Milk and Dairy Products -- 5.2.1.7 Probiotics -- 5.2.2 Nutrition in Obesity -- 5.2.2.1 Probiotics -- 5.2.2.2 Quercetin -- 5.2.2.3 Resveratrol -- 5.2.2.4 Curcumin -- 5.2.2.5 Sulforaphane -- 5.3 Role of Nutrition in the Function of the Cardiovascular System -- 5.4 Cardiac Function in Diabetes and Obesity -- 5.4.1 Cardiac Dysfunction in Diabetes -- 5.4.2 Cardiac Function in Obesity -- 5.5 Diet and Beta-Adrenergic System Relation in Heart Function -- 5.6 Effect of ß-ARs System on Heart Function in Diabetes and Obesity -- 5.7 ß3-ARs in Diabetes and Obesity -- 5.8 Regulation of ß3-ARs in Heart from Diabetic and Obese Mammalians -- 5.9 Conclusions -- Acknowledgment -- Abbreviations -- References -- Chapter 6 High Carbohydrate Diet-Induced Metabolic Syndrome in the Overweight Body: Association between Organ Dysfunction and Insulin Resistance -- 6.1 Introduction -- 6.2 Carbohydrate-Rich Nutrition and MetS -- 6.3 MetS and Cardiovascular Dysfunction -- 6.4 Structural Alterations and Molecular Mechanisms of Cardiovascular Dysfunction in MetS -- 6.5 Electrical Alterations in the Hearts of MetS Individuals -- 6.6 Cellular Abnormalities in Ca2+ Homeostasis and Insulin Action in Mammalian MetS -- 6.7 Conclusions and Prevention Approaches -- Acknowledgments -- Abbreviations.
References -- Chapter 7 Caloric Restriction in Obesity and Diabetic Heart Disease -- 7.1 Introduction -- 7.1.1 Cardiovascular Consequences of Diabetes -- 7.2 Metabolic and Molecular Consequences of Diabetes -- 7.2.1 Oxidative Stress -- 7.2.2 Enhanced Inflammatory Response -- 7.2.3 Enhanced Cardiac Fibrosis -- 7.3 Modern Medical Therapies: Implications for the 'Diabetic' Heart -- 7.3.1 Pharmacological Approach, Bariatric Surgery, Intragastric Balloon -- 7.4 Lifestyle Modification -- 7.4.1 Caloric Restriction (CR) -- 7.4.1.1 CR Intracellular Mode of Action -- 7.4.2 Sirtuins -- 7.4.3 PGC-1a -- 7.5 Summary and Future Perspectives -- Abbreviations -- References -- Chapter 8 Personalized Nutrition in Children with Crohn Disease -- 8.1 Introduction -- 8.2 Crohn Disease: An Inflammatory Bowel Disease -- 8.2.1 Crohn Disease and Ulcerative Colitis -- 8.2.2 Pathogenesis of IBD -- 8.2.3 Presentation and Epidemiology of IBD -- 8.2.4 Diagnosis of CD -- 8.3 Relevance of Nutrition and Dietary Factors in the Development of IBD -- 8.4 Nutritional Impacts of CD in Children -- 8.5 Nutritional Therapy for Children with Active CD -- 8.5.1 Induction of Remission with Exclusive Enteral Nutrition -- 8.6 General Aspects of Nutritional Management in Children with IBD -- 8.6.1 Overall Nutritional Care -- 8.6.2 Dietary Management of Functional Symptoms in Children with CD -- 8.7 Application of Current Understanding to the Development of Personalized Nutrition for Children with CD -- 8.7.1 Concepts to Guide Personalized Nutrition -- 8.7.2 Personalization of Nutritional Therapy to Induce Remission -- 8.7.3 Patient and Disease-Specific Factors to Guide Dietary Choices -- 8.7.4 Nutrigenomics, Nutrigenetics and Nutriepigenetics -- 8.8 Conclusions -- Abbreviations -- References -- Chapter 9 Personalized Nutrition in Chronic Kidney Disease: A New Challenge.
9.1 Chronic Kidney Disease: An Epidemic That Reflects Socio-Economic Differences -- 9.1.1 Kidney Diseases Are Not Rare: A Problem of Measure -- 9.1.2 The Main Markers of Kidney Function Are Also Basic Nutritional Markers -- 9.1.3 CKD Assessment: What Is Missed -- 9.1.4 The Epidemiology of Kidney Diseases Follows Wealth Distribution -- 9.2 Nutritional Approach to CKD: Ten Reasons Why One Size Does Not Fit All -- 9.2.1 Kidney Diseases Are Different -- 9.2.2 CKD Phases Are Different -- 9.2.3 Comorbidity Is Different -- 9.2.4 Cultures Are Different -- 9.2.5 Dietary Habits Are Different -- 9.2.6 Availability of Nutritional Support Is Different -- 9.2.7 Nephrologists (and Dietitians) Are Different -- 9.2.8 Life Phases Are Different -- 9.2.9 Patients Are Different -- 9.2.10 Most of the Previous Points May Change -- 9.3 Nutritional Issues in Different Phases of CKD -- 9.3.1 Early CKD Phases: Nephron Sparing -- 9.3.2 Late CKD Phases: Retarding Dialysis Start -- 9.3.3 Dialysis: Preserving Nutritional Status -- 9.3.4 Kidney Transplantation: Preserving Nutritional Status and Slowing CKD Progression -- 9.4 Some Suggestions on Specific Nutritional Issues in Different Diseases -- 9.4.1 Nephrotic Syndrome and the Case of Focal Segmental Glomerulosclerosis -- 9.4.2 Obesity-Related Kidney Disease and Diabetic Nephropathy -- 9.4.3 Autosomal Dominant Polycystic Kidney Disease (ADPKD) -- 9.4.4 Interstitial Disorders and Kidney Stones -- 9.4.5 Kidney Donation -- 9.5 Nutritional Issues in Particular CKD Populations -- 9.5.1 Pregnant Women with CKD -- 9.5.2 Children with CKD -- 9.6 What This Review Did Not Discuss: Suggestions for Further Research -- 9.7 Concluding Remarks -- Abbreviations -- References -- Chapter 10 Personalized Nutrition in Hypercholesterolemia -- 10.1 Personalized Nutrition in Hypercholesterolemia -- 10.2 Cardiovascular Diseases (CVD).
10.3 Coronary Heart Disease (CHD).
Record Nr. UNINA-9910818670603321
Boca Raton, Florida ; ; London, England ; ; New York : , : CRC Press, , [2020]
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui